This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version    RSS    Subscribe    Unsubscribe    Archive    Media Kit Feb. 25, 2013

Home   The Society   Meetings   Advocacy   Contact Us

 

Bill would allow research on organ donations between HIV patients
SCVNews.com    Share    Share on FacebookTwitterShare on LinkedinE-mail article
U.S. Sens. Barbara Boxer, D-Calif., and Tom Coburn, R-Okla., introduced the HOPE Act (HIV Organ Policy Equity Act) – legislation that would end the federal ban on federal research into organ donations from HIV-positive donors to HIV-positive recipients. More



 SOCIETY NEWS


ASTS member recognition in Chimera
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
ASTS' member magazine, Chimera, focuses on our members and their activities. We feature news about career moves, hires, and awards in "People and Places" and profile transplant programs in "Across the Field." Please consider taking advantage of this easy way to gain recognition for your hard work! The next deadline is March 15. For questions or to submit a profile, contact diane.mossholder@asts.org.

ASTS Transplant Center Policy Library is here to help!
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The ASTS Transplant Center Policy Library is a dynamic subscription service of sample policies and templates help you successfully manage and navigate the growing regulatory and quality improvement environment. It is available as an annual subscription in the ASTS Store — subscribe today! More

Have You Paid Your ASTS Member Dues?
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
To register for the American Transplant Congress at member rates, you must pay your ASTS membership dues by April 1, 2013. You should have received an invoice at the end of last year; if you have questions, email asts@asts.org.


 TOP NEWS


Novartis drug Zortress® is first in over a decade approved by FDA to prevent organ rejection in adult liver transplant patients
Novartis    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Zortress® (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant. Zortress is the first mammalian target of rapamycin (mTOR) inhibitor approved for use following liver transplantation. It is also the first immunosuppressant approved by the FDA in over a decade for use following liver transplantation. More

Donor risk factors, retrieval technique, preservation and ischemia/reperfusion injury in pancreas transplantation
Current Opinion in Organ Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pancreas transplantation is still hampered by a high incidence of early graft loss, and organ quality concerns result in high nonrecovery/discard rates. Demographic donor characteristics, surgical retrieval strategy, preservation fluid and ischemia time are crucial factors in the process of organ selection and are discussed in this review. More

Radiation exposure high prior to kidney transplantation
Renal & Urology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A study found kidney transplant recipients are exposed to large amounts of ionizing radiation from medical imaging as part of their pre-transplant evaluation. Dr. Anup M. Patel and colleagues at Saint Barnabas Medical Center in Livingston, N.J., reviewed the medical records of 172 kidney transplant recipients who underwent 905 medical imaging procedures involving ionizing radiation. Of these, 28 were exposed to high dose (more than 50 and up to 100 mSv) and 23 were exposed to very high dose (more than 100 mSv) cumulative effective radiation. More

Cardiovascular events in kidney transplant patients linked to CMV
Renal & Urology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pre-transplant cytomegalovirus (CMV) exposure and post-transplant CMV replication contribute to an elevated risk of cardiovascular events in kidney transplant recipients, according to investigators. Cecile Courivaud, MD, of Saint Jacques Hospital in Besancon, France, and colleagues studied 570 renal transplant recipients (RTR) who had a follow-up of 87 months. More

NORA, Organ Recovery Transportation Specialists

NORA, the Nationwide Organ Recovery Transport Alliance can help your OPO or Transplant Center! NORA services are tailored to serve all of your organization's transportation needs. Whether by Air, Ground, Local or Long Distance, one call to NORA does it all! Click here for the full story.


Non-invasive biomarkers to guide management following renal transplantation: The need for a multiplatform approach
Current Opinion on Organ Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
It has become clear that to obtain a test suitable for clinical purposes, combinations of markers are required to identify specific clinical phenotypes. Identification and validation of such marker sets in large cohorts is urgently required to allow progression to clinical trials with the ultimate goal of offering recipients personalized anti-rejection therapy regimes. More

Low-dose steroids associated with milder histological changes after pediatric liver transplantation
Liver Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Controversy remains about the role of protocol liver biopsy for symptom-free recipients and about the long-term use of low-dose steroids after pediatric liver transplantation (LT). A recent national cross-sectional study examined pediatric recipients who underwent LT between 1987 and 2007. Researchers concluded continuing low-dose steroids indefinitely after pediatric LT may have a positive effect on the long-term histological state of the liver graft. More

Platelet count predictive of mortality in patients awaiting liver transplant
Healio    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Patients with low platelet counts on a waiting list for liver transplantation had higher death rates and shorter survival times than those with higher platelet counts in a recent study. Researchers performed tests and volumetric liver measurements on 181 patients scheduled for liver transplantation between January 2001 and April 2006, with follow-up through January 2011. More

Low-dose steroids associated with milder histological changes after pediatric liver transplantation
Liver Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Controversy remains about the role of protocol liver biopsy for symptom-free recipients and about the long-term use of low-dose steroids after pediatric liver transplantation (LT). We conducted a national cross-sectional study of pediatric recipients who underwent LT between 1987 and 2007. Liver biopsy samples were taken from 54 patients (82 percent of survivors) after a median posttransplant follow-up of 11 years, and they were reviewed by two pathologists blinded to the clinical data. More


 

ASTS NewsBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Tammy Gibson, Content Editor, 469.420.2677   
Contribute news

This edition of the ASTS NewsBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Feb. 25, 2013
Feb. 11, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063